Kewaunee Scientific (KEQU) Cash Flow Statement

Click line-items for a historical chart and %

Net earnings	2.87M
Depreciation	1.3M
Bad debt provision	23K
Provision for deferred income tax expense
Decrease (increase) in receivables	-1.23M
Decrease in inventories	-1.16M
Decrease in accounts payable and other accrued expenses	456K
Increase in deferred revenue	330K
Other, net	-434K
Net cash used in operating activities
Capital expenditures	-1.76M
(Increase) decrease in restricted cash	-82K
Net cash used in investing activities
Dividends paid	-757K
Increase in short-term borrowings
Payments on long-term debt	-210K
Payments on capital leases
Net proceeds from exercise of stock options (including tax benefit)	141K
Net cash provided by financing activities
Effect of exchange rate changes on cash	-83K
Increase in cash and cash equivalents	2.36M
Cash and cash equivalents, beginning of period	5.22M
Cash and cash equivalents, end of period	7.58M

Entities mentioned with KEQU

View All Entities